Wed, Dec 24, 2014, 11:16 PM EST - U.S. Markets closed early today


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrttwelve chrttwelve May 20, 2010 11:31 PM Flag

    The seven worst PFE declines in a 20-month period over the last ten years

    01) Down 38.1%. From $41.89 on 03/04/02 to $25.92 on 07/22/02. Final dive to the bottom of the 2000-2002 bear market.

    02) Down 36.1%. From $18.27 on 01/02/09 to $11.66 on 03/02/09. Final dive to the bottom of the 17-montb market crash as well as the halving of the dividend and Obamacare fears.

    03) Down 27.6%. From $19.97 on 08/15/08 to $14.45 on 11/20/08. LEH bankruptcy and the inability of a major cash management fund to pay 100 cents on the dollar. Over just a four-session period from the 10/06 close to the 10/10 close, Pfizer plunged 20.1% from $18.94 to $15.14.

    04) Down 27.1%. From $28.90 on 06/23/05 to $21.06 on 10/26/05. First there were worries over reports of Viagra causing blindness in some men. Then McKinnnell had to pull too-optimistic Lipitor growth estimates rendered in early April. And finally there were fears that Pfizer could lose the Lipitor domestic patent infringement case against Ranbaxy.

    05) Down 25.9%. From $32.77 on 09/08/04 to $24.19 on 12/20/04. First was MRK yanking Vioxx and then there was the negative Celebrex test in colon polyps subjects.

    06) Down 24.8%. From $47.44 on 12/19/00 to $35.67 on 03/22/01. Uncertainties of McKinnell replacing Steere and an overall lousy market. The stoick was way overvalued anyway and it didn't take that much for it to tank.

    07) Down 23.9%. From $20.00 on 01/19/10 to $15.23 on 05/20/10. A poorly-received Q4-09 earnings report, the failure of Dimebon and the decimation of the euro.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
31.42-0.03(-0.10%)Dec 24 1:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.